MARKET EYE-Shasun Pharmaceuticals falls on Vertex drug warning

Thu Dec 20, 2012 2:03pm IST

Related Topics

Stocks

   

* Shasun Pharmaceuticals falls 6 percent after its
Vertex Pharmaceuticals warned on Wednesday its
hepatitis C drug Incivek, which is used in conjunction with two
other products, can cause serious, potentially fatal skin
reactions. 
* Shasun has a long-term agreement with Vertex for supply of
active pharmaceutical ingredient for the Hepatitis C drug.
* "There would be incremental impact on Shasun as about 25
percent of FY13 profits were expected to come in from Incivek
supply," said Surya Patra, an analyst tracking the sector at
Systematix Shares & Stocks.

 (abhishek.vishnoi@thomsonreuters.com /;
abhishek.vishnoi.reuters.com@reuters.net)
FILED UNDER:

Aviation

REUTERS SHOWCASE

Global Economy

Global Economy

EU leaders agree investment package to boost economy.  Full Article 

Oil Prices

Oil Prices

Brent steady below $60, heads for 4th weekly decline as oversupply persists.  Full Article 

Chinese Economy

Chinese Economy

China revises up size of economy in 2013 by 3.4 percent.  Full Article 

Reuters Exclusive

Reuters Exclusive

Google aiming to go straight into car with next Android – sources.  Full Article 

Reuters Poll

Reuters Poll

BSE Sensex to hit 32,980 by December 2015  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage